JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M801492200 on May 22, 2008

J. Biol. Chem., Vol. 283, Issue 28, 19854-19863, July 11, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/28/19854    most recent
M801492200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Adachi, N.
Right arrow Articles by Saito, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adachi, N.
Right arrow Articles by Saito, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Enzymological Analysis of Mutant Protein Kinase C{gamma} Causing Spinocerebellar Ataxia Type 14 and Dysfunction in Ca2+ Homeostasis*Formula

Naoko Adachi{ddagger}, Takeshi Kobayashi§, Hideyuki Takahashi{ddagger}, Takumi Kawasaki{ddagger}, Yasuhito Shirai{ddagger}, Takehiko Ueyama{ddagger}, Toshio Matsuda, Takahiro Seki||, Norio Sakai||, and Naoaki Saito{ddagger}1

From the {ddagger}Laboratory of Molecular Pharmacology, Biosignal Research Center, Kobe University, Kobe 657-8501, the §Department of Physiology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, the Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, and the ||Department of Molecular and Pharmacological Neuroscience, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima 734-8551, Japan

Spinocerebellar ataxia type 14 (SCA14) is an autosomal dominant neurodegenerative disease caused by mutations in protein kinase C{gamma} (PKC{gamma}). Interestingly, 18 of 22 mutations are concentrated in the C1 domain, which binds diacylglycerol and is necessary for translocation and regulation of PKC{gamma} kinase activity. To determine the effect of these mutations on PKC{gamma} function and the pathology of SCA14, we investigated the enzymological properties of the mutant PKC{gamma}s. We found that wild-type PKC{gamma}, but not C1 domain mutants, inhibits Ca2+ influx in response to muscarinic receptor stimulation. The sustained Ca2+ influx induced by muscarinic receptor ligation caused prolonged membrane localization of mutant PKC{gamma}. Pharmacological experiments showed that canonical transient receptor potential (TRPC) channels are responsible for the Ca2+ influx regulated by PKC{gamma}. Although in vitro kinase assays revealed that most C1 domain mutants are constitutively active, they could not phosphorylate TRPC3 channels in vivo. Single molecule observation by the total internal reflection fluorescence microscopy revealed that the membrane residence time of mutant PKC{gamma}s was significantly shorter than that of the wild-type. This fact indicated that, although membrane association of the C1 domain mutants was apparently prolonged, these mutants have a reduced ability to bind diacylglycerol and be retained on the plasma membrane. As a result, they fail to phosphorylate TRPC channels, resulting in sustained Ca2+ entry. Such an alteration in Ca2+ homeostasis and Ca2+-mediated signaling in Purkinje cells may contribute to the neurodegeneration characteristic of SCA14.


Received for publication, February 25, 2008 , and in revised form, April 16, 2008.

* This work was supported in part by a Grant-in-aid for Scientific Research from the Global Center of Excellence (COE) Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from the Astellas Foundation for Research on Metabolic Disorders and Takeda Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S4 and Videos 1-4.

1 To whom correspondence should be addressed. Tel.: 81-78-803-5962; Fax: 81-78-803-5971; E-mail: naosaito{at}kobe-u.ac.jp.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.